Tempus AI Stock Plunges 28.9% in Three Months: What's Next? [Yahoo! Finance]
Myriad Genetics, Inc.'s (NASDAQ:MYGN) Intrinsic Value Is Potentially 97% Above Its Share Price [Yahoo! Finance]
MYGN Stock Might Gain From the New Recognition of RiskScore Study [Yahoo! Finance]
Myriad Genetics' RiskScore Study Named One of the Top 10 Significant Advances in Genomic Medicine in American Journal of Human Genetics [Yahoo! Finance]
Myriad Genetics’ RiskScore Study Named One of the Top 10 Significant Advances in Genomic Medicine in American Journal of Human Genetics